John M Murray
Title
Cited by
Cited by
Year
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
RT Mitsuyasu, TC Merigan, A Carr, JA Zack, MA Winters, C Workman, ...
Nature medicine 15 (3), 285-292, 2009
3062009
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
JM Murray, S Emery, AD Kelleher, M Law, J Chen, DJ Hazuda, ...
Aids 21 (17), 2315-2321, 2007
2172007
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients
T Volz, M Lutgehetmann, P Wachtler, A Jacob, A Quaas, JM Murray, ...
Gastroenterology 133 (3), 843-852, 2007
2062007
Kinetics of acute hepatitis B virus infection in humans
SA Whalley, JM Murray, D Brown, GJM Webster, VC Emery, GM Dusheiko, ...
The Journal of experimental medicine 193 (7), 847-854, 2001
1922001
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
M Markowitz, X Jin, A Hurley, V Simon, B Ramratnam, M Louie, ...
The Journal of infectious diseases 186 (5), 634-643, 2002
1562002
Dynamics of hepatitis B virus clearance in chimpanzees
JM Murray, SF Wieland, RH Purcell, FV Chisari
Proceedings of the National Academy of Sciences 102 (49), 17780-17785, 2005
1492005
Optimal control for a cancer chemotheraphy problem with general growth and loss functions
JM Murray
Mathematical Biosciences 98 (2), 273-287, 1990
1361990
Long‐term survival and concomitant gene expression of ribozyme‐transduced CD4+ T‐lymphocytes in HIV‐infected patients
JL Macpherson, MP Boyd, AJ Arndt, AV Todd, GC Fanning, JA Ely, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2005
1322005
CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T …
S Fernandez, S Tanaskovic, K Helbig, R Rajasuriar, M Kramski, ...
The Journal of infectious diseases 204 (12), 1927-1935, 2011
1012011
Some optimal control problems in cancer chemotherapy with a toxicity limit
JM Murray
Mathematical Biosciences 100 (1), 49-67, 1990
971990
Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty
JM Murray, GR Kaufmann, PD Hodgkin, SR Lewin, AD Kelleher, ...
Immunology and Cell Biology 81 (6), 487-495, 2003
942003
The half‐life of hepatitis B virions
JM Murray, RH Purcell, SF Wieland
Hepatology 44 (5), 1117-1121, 2006
852006
The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users
JM Murray, MG Law, Z Gao, JM Kaldor
International Journal of Epidemiology 32 (5), 708-714, 2003
852003
In vivo proliferation of hepadnavirus‐infected hepatocytes induces loss of covalently closed circular DNA in mice
M Lutgehetmann, T Volz, A Köpke, T Broja, E Tigges, AW Lohse, E Fuchs, ...
Hepatology 52 (1), 16-24, 2010
812010
HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy
JM Murray, JJ Zaunders, KL McBride, Y Xu, M Bailey, K Suzuki, ...
Journal of virology 88 (6), 3516-3526, 2014
802014
Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals
JM Murray, AD Kelleher, DA Cooper
Journal of virology 85 (20), 10798-10805, 2011
752011
The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis
A Vallely, A Page, S Dias, P Siba, T Lupiwa, G Law, J Millan, DP Wilson, ...
PloS one 5 (12), e15586, 2010
752010
A model of primary HIV-1 infection
JM Murray, G Kaufmann, AD Kelleher, DA Cooper
Mathematical Biosciences 154 (2), 57-85, 1998
701998
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
KK Koelsch, C Boesecke, K McBride, L Gelgor, P Fahey, V Natarajan, ...
Aids 25 (17), 2069-2078, 2011
692011
Optimal control for a stochastic model of cancer chemotherapy
AJ Coldman, JM Murray
Mathematical biosciences 168 (2), 187-200, 2000
672000
The system can't perform the operation now. Try again later.
Articles 1–20